ストックスクリーナーアプリを入手
7.16
6.07%
0.41
アフターアワーズ：
7.20
0.04
+0.56%
Precigen Inc (PGEN) 最新ニュース
Precigen (PGEN) Stock: Ends Up by 6.30% at $7.17 in the Latest Session; Key Range: Support at $6.81 and Resistance at $7.53 Frame the Range under the Current SnapshotPut Spread Alert - Vinanet
Stock Traders Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat
Alpine Woods Capital Investors LLC Takes $1.31 Million Position in Precigen, Inc. $PGEN - MarketBeat
$Precigen (PGEN.US)$ DCA'd Up. Ready for the next leg higher - Moomoo
Precigen (PGEN) Price and Levels: Finishes 3.05% Higher at $6.75 in the Latest Session; $6.41 and $7.09 Define the Nearby Reference Levels at the CloseCounter Trend Trade - Vinanet
Precigen Inc. (PGEN) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Precigen (NASDAQ:PGEN) Stock Price Up 5.5%Time to Buy? - MarketBeat
Precigen Inc (PGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precigen (NASDAQ:PGEN) Trading Down 5.5%What's Next? - MarketBeat
Are You Looking for a Top Momentum Pick? Why Precigen, Inc. (PGEN) is a Great Choice - Yahoo Finance
Precigen, Inc. (PGEN) Latest Stock News & Headlines - Yahoo! Finance Canada
Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch? - Yahoo Finance
US High Growth Tech Stocks To Watch: 3 Top Picks - simplywall.st
Precigen (PGEN) Q2 2026 Earnings Call Transcript - AOL.com
Precigen (PGEN) Is Up 16.3% After Papsimios-Fueled Return To Profitability And Broad Payer Coverage - webull.com
Precigen (PGEN) Insider Rutul Shah Sells 32,739 Shares - GuruFocus
Precigen jumps 266% on FDA approval but faces h... - Pluang
Wall Street Zen Upgrades Precigen (NASDAQ:PGEN) to "Strong-Buy" - MarketBeat
Precigen: Has To Grow Into Its Valuation - Seeking Alpha
Precigen (NASDAQ:PGEN) COO Sells $224,589.54 in Stock - MarketBeat
COO sale: Precigen (PGEN) insider trades 32,739 shares via plan - Stock Titan
Merck affiliates disclose 4.9% Precigen (NASDAQ: PGEN) ownership - Stock Titan
HC Wainwright Has Positive Outlook for Precigen Q3 Earnings - MarketBeat
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Zacks Research - MarketBeat
Precigen, Inc. (PGEN) Stock Analysis: Strong Growth Potential With An 80% Upside - DirectorsTalk Interviews
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement (PGEN) - Seeking Alpha
PRECIGEN, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $18 FROM $14 - webull.com
Precigen (NASDAQ: PGEN) Form 144 covers 32,739 common shares for sale - Stock Titan
HC Wainwright Predicts Precigen's Q4 Earnings (NASDAQ:PGEN) - MarketBeat
Results: Precigen, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - 富途牛牛
Precigen (NASDAQ:PGEN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Arrowstreet Capital Limited Partnership Acquires Shares of 395,695 Precigen, Inc. $PGEN - MarketBeat
Precigen upgraded to Strong Buy on rising PAPZI... - Pluang
Precigen, Inc. (PGEN) Interactive Stock Chart - Yahoo! Finance Canada
Germantown biopharma Precigen turns first quarterly profit after key drug scores FDA approval - The Business Journals
Precigen (NASDAQ:PGEN) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Precigen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Precigen Inc (PGEN) (Q2 2026) Earnings Call Highlights: Revenue Surges 145% and Net Profit Achieved - GuruFocus
Is Precigen Inc (PGEN) Overvalued After Q2 Earnings Beat? GF Sco - GuruFocus
Earnings call transcript: Precigen tops Q2 2026 forecasts as PAPZIMEOS sales surge - Investing.com
Precigen (NASDAQ:PGEN) Announces Earnings Results - MarketBeat
Precigen, Inc. (PGEN) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Precigen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Precigen (PGEN) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Precigen Inc Earnings Call Transcript - GuruFocus
Earnings Flash (PGEN) Precigen, Inc. Reports Q2 Revenue $55.0M, vs. FactSet Est of $28.0M - marketscreener.com
PGEN: Profitability reached as PAPZIMEOS drives record revenue and broad US adoption - TradingView
PRECIGEN, INC. 2026: Revenue $54.98M, EPS $0.05— 10-Q Summary - TradingView
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth - Yahoo Finance
Precigen earnings set to test gene therapy growth trajectory By Investing.com - Investing.com Nigeria
Precigen earnings set to test gene therapy growth trajectory - Investing.com
Analysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Precision BioSciences (DTIL) - The Globe and Mail
Precigen COO Rutul Shah sells $219,518 in company stock - Investing.com
Precigen COO Rutul Shah sells $219,518 in company stock By Investing.com - Investing.com South Africa
Rutul Shah Sells 33,772 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat
$Precigen (PGEN.US)$ 🏃🏃 Goodbye, brothers - Moomoo
PGEN (PGEN) shareholder Rutul Shah files to sell 33,772 common shares - Stock Titan
Precigen, Inc. Revenue Breakdown – NASDAQ:PGEN - TradingView
Insider Selling: Precigen (NASDAQ:PGEN) CFO Sells 100,000 Shares - MarketBeat
Earnings Preview: Precigen to Report Financial Results Post-market on August 04 - Moomoo
Precigen (PGEN) Projected to Release Earnings on Tuesday - MarketBeat
PGEN|Precigen Inc|Price:5.425|Chg%:+0.025 - TradingKey
Precigen Inc (PGEN) Cash Flow - TradingKey
Precigen Inc (PGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precigen Inc (PGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precigen Inc Revenue Breakdown – DUS:I5X - TradingView
TradingKey - TradingKey
KBC Group NV Makes New Investment in Precigen, Inc. $PGEN - MarketBeat
Precigen Inc Revenue Breakdown – GETTEX:I5X - TradingView
PGEN|Precigen Inc|Price:5.400|Chg%:-0.140 - TradingKey
3.42%
0.62%
大文字化:
|
ボリューム (24 時間):